Effect of adjuvant tamoxifen therapy on thyroid function in postmenopausal women with breast cancer

  • Jamal Zidan
  • , Wolf Rubenstein

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Serum thyroid-stimulating hormone (TSH), free thyroxine (FT4) and total tri-iodothyronine (TT3) concentrations were measured in 45 postmenopausal breast cancer patients before adjuvant treatment with tamoxifen and at 3- and 6-month intervals. A significant increase in TSH (p = 0.002) at the end of 3 months and a subsequent decrease at the end of 6 months was noted. There were no significant changes in TT3 and FT4. We concluded that tamoxifen therapy in postmenopausal women may result in a reversible increase in TSH after 3 months.

Original languageEnglish
Pages (from-to)43-45
Number of pages3
JournalOncology
Volume56
Issue number1
DOIs
StatePublished - Jan 1999
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adjuvant therapy
  • Breast cancer
  • Tamoxifen
  • Thyroid function

Fingerprint

Dive into the research topics of 'Effect of adjuvant tamoxifen therapy on thyroid function in postmenopausal women with breast cancer'. Together they form a unique fingerprint.

Cite this